Publication:
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.

Loading...
Thumbnail Image

Date

2022-11-23

Authors

Ortuzar, Ariana
Fox, María Laura
Vera, Juan Antonio
Lorenzo Vizcaya, Álvaro
Marín Sánchez, Alberto
Llopis Calatayud, Inmaculada
Carbonell, Sara
Álvarez-Larrán, Alberto
Mata Serna, Raquel
Marco Buades, Josefa E

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The SARS-CoV-2 pandemic has favored the expansion of telemedicine. Philadelphia-negative chronic myeloproliferative neoplasms (Ph-MPN) might be good candidates for virtual follow-up. In this study, we aimed to analyze the follow-up of patients with Ph-MPN in Spain during COVID-19, its effectiveness, and acceptance among patients. We present a multicenter retrospective study from 30 centers. Five hundred forty-one patients were included with a median age of 67 years (yr). With a median follow-up of 19 months, 4410 appointments were recorded. The median of visits per patient was 7 and median periodicity was 2.7 months; significantly more visits and a higher frequency of them were registered in myelofibrosis (MF) patients. 60.1% of visits were in-person, 39.5% were by telephone, and 0.3% were videocall visits, with a predominance of telephone visits for essential thrombocythemia (ET) and polycythemia vera (PV) patients over MF, as well as for younger patients (

Description

MeSH Terms

Humans
Aged
Pandemics
Retrospective Studies
Patient Satisfaction
Spain
COVID-19
SARS-CoV-2
Myeloproliferative Disorders
Polycythemia Vera
Primary Myelofibrosis
Thrombocythemia, Essential

DeCS Terms

CIE Terms

Keywords

COVID-19, Follow-up, Patient satisfaction, Ph-MPN, Spain, Telemedicine

Citation